<p>Hypermarcas（OTCMKTS:HYPMY - 获取免费报告）在四月份的空头头寸出现了显著下降。截至 4 月 15 日，空头头寸总计为 16 股，较 3 月 31 日的 3,024 股下降了 99.5%。根据 46,208 股的平均交易量，目前的覆盖天数比率为 0.0 天。公司约有 0.0% 的股份被做空。</p>
<h2>Hypermarcas 股票表现</h2>
<p>HYPMY 股票在周五下跌 0.16 美元，达到 4.43 美元。该公司交易了 1,826 股，相较于其平均交易量 15,350 股。Hypermarcas 的 12 个月低点为 3.62 美元，12 个月高点为 5.50 美元。该股票的 50 日移动平均价格为 4.39 美元，200 日移动平均价格为 4.45 美元。该公司的市值为 31.2 亿美元，市盈率为 13.03，贝塔系数为 0.75。公司的债务与股本比率为 0.61，流动比率为 1.27，速动比率为 0.84。</p>
<p>Hypermarcas（OTCMKTS:HYPMY - 获取免费报告）最后一次公布财报是在 3 月 12 日，报告显示该季度每股收益（EPS）为 0.13 美元。Hypermarcas 的净利润率为 15.71%，股本回报率为 10.27%。该季度的营业收入为 4.1422 亿美元。</p>
<h2>关于 Hypermarcas</h2>
<p>（获取免费报告）</p>
<p>Hypermarcas SA 是一家总部位于巴西的消费健康和制药公司，其股票在美国以 HYPMY 的符号进行场外交易。公司成立于 2000 年代初，总部位于里约热内卢，作为一个控股集团，经营着广泛的医疗保健和个人护理领域的品牌产品组合。</p>
<p>通过其各个子公司，Hypermarcas 开发、生产和销售处方药和非处方药，以及个人护理、婴儿护理、家庭护理和营养补充产品。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，胜过 Hypermarcas</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Hypermarcas 吗？</h2>
<p>在考虑 Hypermarcas 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Hypermarcas 并不在名单上。</p>
<p>虽然 Hypermarcas 目前在分析师中获得了强烈买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

HYPMY

<p>Hypermarcas（OTCMKTS:HYPMY）在四月份的空头头寸显著下降，至 4 月 15 日仅剩 16 股，下降幅度达到 99.5%。这一数字较 3 月 31 日的 3,024 股大幅减少，空头卖出股份约占 0.0%。该股票交易价格下跌至 4.43 美元，市值为 31.2 亿美元，市盈率为 13.03。公司报告上个季度每股收益为 0.13 美元，收入为 4.1422 亿美元，净利润率为 15.71%</p>

<p>Hypermarcas (OTCMKTS:HYPMY - Get Free Report) was the target of a significant decline in short interest in the month of April. As of April 15th, there was short interest totaling 16 shares, a decline of 99.5% from the March 31st total of 3,024 shares. Based on an average trading volume of 46,208 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.</p>
<div class="lb-trans"><p>Hypermarcas（OTCMKTS:HYPMY - 获取免费报告）在四月份的空头头寸出现了显著下降。截至 4 月 15 日，空头头寸总计为 16 股，较 3 月 31 日的 3,024 股下降了 99.5%。根据 46,208 股的平均交易量，目前的覆盖天数比率为 0.0 天。公司约有 0.0% 的股份被做空。</p>
</div><h2>Hypermarcas Stock Performance</h2>
<div class="lb-trans"><h2>Hypermarcas 股票表现</h2>
</div><p>HYPMY stock traded down $0.16 on Friday, reaching $4.43. 1,826 shares of the company were exchanged, compared to its average volume of 15,350. Hypermarcas has a 12 month low of $3.62 and a 12 month high of $5.50. The stock's fifty day moving average price is $4.39 and its 200 day moving average price is $4.45. The firm has a market capitalization of $3.12 billion, a PE ratio of 13.03 and a beta of 0.75. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84.</p>
<div class="lb-trans"><p>HYPMY 股票在周五下跌 0.16 美元，达到 4.43 美元。该公司交易了 1,826 股，相较于其平均交易量 15,350 股。Hypermarcas 的 12 个月低点为 3.62 美元，12 个月高点为 5.50 美元。该股票的 50 日移动平均价格为 4.39 美元，200 日移动平均价格为 4.45 美元。该公司的市值为 31.2 亿美元，市盈率为 13.03，贝塔系数为 0.75。公司的债务与股本比率为 0.61，流动比率为 1.27，速动比率为 0.84。</p>
</div><p>Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last announced its earnings results on Thursday, March 12th. The company reported $0.13 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 15.71% and a return on equity of 10.27%. The business had revenue of $414.22 million for the quarter.</p>
<div class="lb-trans"><p>Hypermarcas（OTCMKTS:HYPMY - 获取免费报告）最后一次公布财报是在 3 月 12 日，报告显示该季度每股收益（EPS）为 0.13 美元。Hypermarcas 的净利润率为 15.71%，股本回报率为 10.27%。该季度的营业收入为 4.1422 亿美元。</p>
</div><h2>About Hypermarcas</h2>
<div class="lb-trans"><h2>关于 Hypermarcas</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.</p>
<div class="lb-trans"><p>Hypermarcas SA 是一家总部位于巴西的消费健康和制药公司，其股票在美国以 HYPMY 的符号进行场外交易。公司成立于 2000 年代初，总部位于里约热内卢，作为一个控股集团，经营着广泛的医疗保健和个人护理领域的品牌产品组合。</p>
</div><p>Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.</p>
<div class="lb-trans"><p>通过其各个子公司，Hypermarcas 开发、生产和销售处方药和非处方药，以及个人护理、婴儿护理、家庭护理和营养补充产品。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Hypermarcas</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Hypermarcas</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Hypermarcas Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Hypermarcas 吗？</h2>
</div><p>Before you consider Hypermarcas, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Hypermarcas 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Hypermarcas 并不在名单上。</p>
</div><p>While Hypermarcas currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Hypermarcas 目前在分析师中获得了强烈买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Hypermarcas (OTCMKTS:HYPMY) 的空头头寸在四月份下降了 99.5%